• Healthcare Professionals

    Healthcare Professionals

    Advanced Wound Care

    Diabetic Foot Ulcer

    Debridement

    ChloraSolv Advanced Wound Care

    ChloraSolv Animal Health
  • Products

    Products

    The Innovation

    ChloraSolv Advanced Wound Care

    ChloraSolv Animal Health
  • About Us

    About US

    About us

    Strategy & Values

    Code of Conduct

    Career
  • R&D

    Research & Development

    Introduction

    The Unique Buffered Hypochlorite Technical Platform

    Advanced Wound Care

    Publications & Articles
  • Investors

    Investors

    Introduction

    Strategy

    Management

    Shares

    Calendar

    Investor Relations Contact
  • Financial Information

    Financial Information

    Introduction

    Annual Reports

    Financial Reports

    Regulatory Information

    Invitations

    List of Owners

    Financial Archive
  • Partnership

    Partnership

    Partnership Philosophy

    Our Partners

    Our Distributors
  • Media

    Media

    Introduction

    Press Releases

    News

    Newsletter

    Events

    Images

    Media Contact
  • Contact
logo

Press Releases SWE

Göteborgs Tingsrätt godkänner konkursansökan för RLS Global AB (publ)

RLS Global ansöker om konkurs

RLS Global inleder strategisk granskningsprocess i syfte att kommersialisera ChloraSolv

RLS Global och Convatec har gemensamt beslutat att avbryta samarbetsavtalet

Första patienten inkluderad i ny klinisk studie på trycksår

ChloraSolv rekommenderas för UK CA-certifiering som krävs för den brittiska marknaden efter Brexit

RLS Global AB (publ) offentliggör delårsrapport för perioden april–juni 2023

RLS Global AB (publ) upptar ett kortfristigt lån om 5,0 MSEK

RLS Global utser Torbjörn Sannerstedt till ny Chief Financial Officer

Ny tillförordnad VD för RLS Global

  • 1
  • 2
  • 3
  • …
  • 11

© 2020 RLS Global. All rights reserved.

Privacy Preference Center

Privacy Preferences

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

  • How does it work?
  • Using ChloraSolv

How does it work?

  • ChloraSolv provides a moist alkaline pH environment that softens and dissolves necrotic tissue and makes it easy to remove by using a blunt instrument.
  • ChloraSolv contains sodium hypochlorite that has the ability to degrade necrotic tissue and facilitate the cleaning.
  • ChloraSolv contains sodium hypochlorite that is a broad-spectrum anti-microbiological agent that reduces the microbiological load as shown in vitro (pH Eur 5.1.11).

Using ChloraSolv
ChloraSolv consists of two solutions provided in a double syringe. The solutions are mixed to form a gel at the time of use. The gel is applied on the wound bed and allowed to act for 2 minutes to soften the devitalized tissue. A blunt instrument is then used to help in the mechanical removal devitalized tissue from the application site. Finish the procedure with a second application of the gel directly onto the wound area to completely clean the wound bed.

ChloraSolv – a valuable addition in the treatment of infected diabetic foot ulcers providing non-surgical debridement

Cookies

We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies.

We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies.I agreeCookie Policy